IMMIX BIOPHARMA INC (IMMX) Stock Analyst Ratings
NASDAQ:IMMX - Nasdaq - US45258H1068 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to IMMX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 305.68% above the current price.
IMMX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMMX.
In the previous month the buy percentage consensus was at a similar level.
IMMX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-01 | HC Wainwright & Co. | Initiate | Buy |
| 2023-08-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-02-22 | Roth MKM | Initiate | Buy |